1. Home
  2. ASTI vs GRDX Comparison

ASTI vs GRDX Comparison

Compare ASTI & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ascent Solar Technologies Inc.

ASTI

Ascent Solar Technologies Inc.

HOLD

Current Price

$7.97

Market Cap

40.9M

Sector

Technology

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

N/A

Current Price

$5.27

Market Cap

39.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASTI
GRDX
Founded
2005
N/A
Country
United States
United Kingdom
Employees
N/A
2
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.9M
39.3M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ASTI
GRDX
Price
$7.97
$5.27
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
2.9M
155.1K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
70.23
N/A
EPS
N/A
N/A
Revenue
$10,398,149.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
163.25
N/A
52 Week Low
$1.40
$1.87
52 Week High
$9.87
$6.93

Technical Indicators

Market Signals
Indicator
ASTI
GRDX
Relative Strength Index (RSI) 58.26 55.12
Support Level $2.99 $2.16
Resistance Level $9.37 $6.93
Average True Range (ATR) 1.79 0.65
MACD 0.06 -0.09
Stochastic Oscillator 59.03 34.17

Price Performance

Historical Comparison
ASTI
GRDX

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: